Table 3.

Univariate Logistic Regression Analysis for Clinically Meaningful Outcome Represented by Mean MAL QOM Scale (≥3)

	At 2 Weeks (Immediate Posttreatment)				At 12 Months
Variables	Estimate (β)	Standard Error	Wald Chi-Square	P Value	Estimate (β)	Standard Error	Wald Chi-Square	P Va l ue
Group (1 = treatment)	0.946	0.352	7.226	.007	0.799	0.332	5.790	.016
Age	−0.009	0.014	0.383	.536	−0.022	0.013	2.988	.084
Gender (1 = female)	−0.495	0.373	1.759	.185	−0.545	0.356	2.334	.127
Type of stroke	−0.289	0.555	0.270	.603	−0.423	0.547	0.594	.441
Side of stroke (1 = left)	−0.644	0.349	3.406	.065	−0.572	0.331	2.983	.084
Concordance	−0.136	0.642	0.045	.833	−0.360	0.604	0.356	.551
Time after stroke (days)	−0.006	0.003	3.636	.057	−0.006	0.003	3.890	.049
Functional level (1 = high)	2.947	1.033	8.133	.004	1.473	0.560	6.919	.009
Pretreatment mean MAL AOU	1.946	0.320	37.108	<.0001	1.465	0.251	34.046	<.0001
Pretreatment mean MAL QOM	2.380	0.392	36.936	<.0001	1.774	0.294	36.474	<.0001
Pretreatment mean WMFT FAS	3.597	0.677	28.229	<.0001	2.265	0.481	22.170	<.0001
Pretreatment log mean WMFT time	−1.934	0.327	34.905	<.0001	−1.357	0.243	31.132	<.0001
Pretreatment FMA motor	0.123	0.024	26.514	<.0001	0.050	0.017	8.993	.003
Spasticity: elbow flexors	−0.080	0.368	0.047	.829	−0.026	0.352	0.006	.941
Spasticity: forearm pronators	−0.517	0.362	2.041	.153	−0.083	0.346	0.057	.811
Spasticity: wrist flexors	−0.640	0.359	3.175	.075	−0.113	0.345	0.107	.743
Sensory impairment (light touch)	−0.756	0.370	4.184	.041	−0.538	0.345	2.425	.119
Sensory impairment (proprioception)	−0.708	0.431	2.702	.100	−1.430	0.478	8.931	.003
Impaired visual perception	−0.398	0.349	1.299	.255	−0.179	0.331	0.292	.589

MAL = Motor Activity Log; QOM = Quality of Movement; AOU = Amount of Use; WMFT = Wolf Motor Function Test; FAS = functional ability scale; FMA = Fugl-Meyer Assessment.